On the other hand, B-cell lymphoma, GBM, acute myeloid leukemia glioma, hepatocellular carcinoma, prostate adenocarcinoma and thymoma exhibited significantly high levels of GSN compared to the expression levels in normal tissues. This evidence concerns the gene GSN and glioblastoma.